Functional effects of single nucleotide polymorphisms in the coding region of human N-acetyltransferase 1
Open Access
- 2 October 2007
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 8 (5) , 339-348
- https://doi.org/10.1038/sj.tpj.6500483
Abstract
Genetic variants of human N-acetyltransferase 1 (NAT1) are associated with cancer and birth defects. N- and O-acetyltransferase catalytic activities, Michaelis–Menten kinetic constants (Km and Vmax) and steady-state expression levels of NAT1-specific mRNA and protein were determined for the reference NAT1*4 and variant human NAT1 haplotypes possessing single nucleotide polymorphisms (SNPs) in the open reading frame. Although none of the SNPs caused a significant effect on steady-state levels of NAT1-specific mRNA, C97T(R33stop), C190T(R64W), C559T (R187stop) and A752T(D251V) each reduced NAT1 protein level and/or N- and O-acetyltransferase catalytic activities to levels below detection. G560A(R187Q) substantially reduced NAT1 protein level and catalytic activities and increased substrate Km. The G445A(V149I), G459A(synonymous) and T640G(S214A) haplotype present in NAT1*11 significantly (PKm, catalytic activity, mRNA or protein level. These results suggest heterogeneity among slow NAT1 acetylator phenotypes.Keywords
This publication has 34 references indexed in Scilit:
- A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate SpecificityScience, 2007
- Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2Pharmacogenetics and Genomics, 2007
- Risk of limb deficiency defects associated with NAT1, NAT2, GSTT1, GSTM1, and NOS3 genetic variants, maternal smoking, and vitamin supplement intakeAmerican Journal of Medical Genetics Part A, 2006
- Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1Pharmacogenetics and Genomics, 2006
- Loss of function polymorphisms in NAT1 protect against spina bifidaHuman Genetics, 2006
- The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifidaBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl‐N‐transferase 1 (NAT1), and risk for orofacial cleftsBirth Defects Research Part A: Clinical and Molecular Teratology, 2004
- Maternal Smoking and the Risk of Orofacial CleftsEpidemiology, 2004
- Pharmacogenetics of the arylamine N-acetyltransferasesThe Pharmacogenomics Journal, 2002
- Functional polymorphism of the human arylamine JV-acetyltransferase type 1 gene caused by C190T and G560A mutationsPharmacogenetics, 1998